Comparison of overall survival between antiviral‐induced viral suppression and inactive phase chronic hepatitis B patients (Englisch)
- Neue Suche nach: Cho, Y. Y.
- Neue Suche nach: Lee, J.‐H.
- Neue Suche nach: Chang, Y.
- Neue Suche nach: Nam, J. Y.
- Neue Suche nach: Cho, H.
- Neue Suche nach: Lee, D. H.
- Neue Suche nach: Cho, E. J.
- Neue Suche nach: Yu, S. J.
- Neue Suche nach: Lee, J. M.
- Neue Suche nach: Kim, Y. J.
- Neue Suche nach: Yoon, J.‐H.
- Neue Suche nach: Cho, Y. Y.
- Neue Suche nach: Lee, J.‐H.
- Neue Suche nach: Chang, Y.
- Neue Suche nach: Nam, J. Y.
- Neue Suche nach: Cho, H.
- Neue Suche nach: Lee, D. H.
- Neue Suche nach: Cho, E. J.
- Neue Suche nach: Yu, S. J.
- Neue Suche nach: Lee, J. M.
- Neue Suche nach: Kim, Y. J.
- Neue Suche nach: Yoon, J.‐H.
In:
Journal of Viral Hepatitis
;
25
, 10
;
1161-1171
;
2018
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Comparison of overall survival between antiviral‐induced viral suppression and inactive phase chronic hepatitis B patients
-
Beteiligte:Cho, Y. Y. ( Autor:in ) / Lee, J.‐H. ( Autor:in ) / Chang, Y. ( Autor:in ) / Nam, J. Y. ( Autor:in ) / Cho, H. ( Autor:in ) / Lee, D. H. ( Autor:in ) / Cho, E. J. ( Autor:in ) / Yu, S. J. ( Autor:in ) / Lee, J. M. ( Autor:in ) / Kim, Y. J. ( Autor:in )
-
Erschienen in:Journal of Viral Hepatitis ; 25, 10 ; 1161-1171
-
Verlag:
-
Erscheinungsdatum:01.10.2018
-
Format / Umfang:11 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 25, Ausgabe 10
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1107
-
Issue Information| 2018
- 1110
-
Transplanting organs from hepatitis B positive donors: Is it safe? Is it ethical?Anwar, Nadeem / Sherman, Kenneth E. et al. | 2018
- 1116
-
Hepatitis B virus infection in Taiwan: The role of NTCP rs2296651 variant in relation to sexNfor, O. N. / Wu, M.‐F. / Debnath, T. / Lee, C.‐T. / Lee, W. / Liu, W.‐H. / Tantoh, D. M. / Hsu, S.‐Y. / Liaw, Y.‐P. et al. | 2018
- 1121
-
Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co‐infected patients from Western AfricaBoyd, A. / Moh, R. / Maylin, S. / Abdou Chekaraou, M. / Mahjoub, N. / Gabillard, D. / Anglaret, X. / Eholié, S. P. / Delaugerre, C. / Danel, C. et al. | 2018
- 1132
-
Detection of in vivo hepatitis B virus surface antigen mutations—A comparison of four routine screening assaysGencay, M. / Seffner, A. / Pabinger, S. / Gautier, J. / Gohl, P. / Weizenegger, M. / Neofytos, D. / Batrla, R. / Woeste, A. / Kim, H. S. et al. | 2018
- 1139
-
Serum NGAL can act as an early renal safety biomarker during long‐term nucleos(t)ide analogue antiviral therapy in chronic hepatitis BCarey, I. / Byrne, R. / Childs, K. / Horner, M. / Bruce, M. / Wang, B. / Dusheiko, G. / Agarwal, K. et al. | 2018
- 1151
-
A novel index using routine clinical parameters for predicting significant liver inflammation in chronic hepatitis BWang, J. / Xia, J. / Zhang, R. / Yan, X. / Yang, Y. / Zhao, X. / Chang, H. / Wang, G. / Chen, G. / Liu, Y. et al. | 2018
- 1161
-
Comparison of overall survival between antiviral‐induced viral suppression and inactive phase chronic hepatitis B patientsCho, Y. Y. / Lee, J.‐H. / Chang, Y. / Nam, J. Y. / Cho, H. / Lee, D. H. / Cho, E. J. / Yu, S. J. / Lee, J. M. / Kim, Y. J. et al. | 2018
- 1172
-
Systematic review and meta‐analysis: Development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis e antigen seroconversionZhou, T.‐C. / Lai, X. / Feng, M.‐H. / Tang, Y. / Zhang, L. / Wei, J. et al. | 2018
- 1180
-
Shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infectionMartinello, M. / Bhagani, S. / Gane, E. / Orkin, C. / Cooke, G. / Dore, G. J. / Petoumenos, K. / Applegate, T. L. / Tu, E. / Marks, P. et al. | 2018
- 1189
-
Early development of de novo hepatocellular carcinoma after direct‐acting agent therapy: Comparison with pegylated interferon‐based therapy in chronic hepatitis C patientsYoo, S. H. / Kwon, J. H. / Nam, S. W. / Kim, H. Y. / Kim, C. W. / You, C. R. / Choi, S. W. / Cho, S. H. / Han, J.‐Y. / Song, D. S. et al. | 2018
- 1197
-
Effectiveness and cost‐effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs: The case of FranceCousien, A. / Tran, V. C. / Deuffic‐Burban, S. / Jauffret‐Roustide, M. / Mabileau, G. / Dhersin, J.‐S. / Yazdanpanah, Y. et al. | 2018
- 1208
-
Epidemiological characteristics and associated factors of acute hepatitis A outbreak among HIV‐coinfected men who have sex with men in Taiwan, June 2015‐December 2016Cheng, C.‐Y. / Wu, H.‐H. / Zou, H. / Lo, Y.‐C. et al. | 2018
- 1216
-
Younger age and language barriers are associated with nonadherence to clinical follow‐up in hepatitis B treatmentChi, H. / Japhary, A. / de Man, R. A. / de Knegt, R. J. / Janssen, H. L. A. / Hansen, B. E. et al. | 2018
- 1220
-
Is revaccination required in children who received a full primary vaccination against hepatitis B in infancy? A letter in response to Changes and analysis of anti‐HBs titres after primary immunization in 1‐to 16‐year‐old Chinese children: A hospital‐based studyZhou, Y. / Zhou, Y.‐H. et al. | 2018
- 1221
-
Response to letter to the editor: Is revaccination required in children who received a full primary vaccination against hepatitis B in infancy?! A response letter from the authors of Changes and analysis of anti‐HBs titres after primary immunization in 1‐to 16‐year‐old Chinese children: A hospital‐based studyYue, Xiaomei / Yang, Yuting / Zhao, Yao et al. | 2018